| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S00415-006-0298-5 |
| P8608 | Fatcat ID | release_wty5u5dvdrf7rcwpluhoaw7ky4 |
| P698 | PubMed publication ID | 17318713 |
| P50 | author | Tadeusz Dobosz | Q57426365 |
| P2093 | author name string | Jerzy Leszek | |
| Bogusław Paradowski | |||
| Malgorzata Jaremko | |||
| Leszek Noga | |||
| P2860 | cites work | Failure to detect Chlamydia pneumoniae in brain sections of Alzheimer's disease patients | Q24551398 |
| Identification and localization of Chlamydia pneumoniae in the Alzheimer's brain | Q28283487 | ||
| Chelex 100 as a medium for simple extraction of DNA for PCR-based typing from forensic material | Q28289686 | ||
| Herpes simplex virus type 1 in brain and risk of Alzheimer's disease | Q28302548 | ||
| Failure to detect Chlamydia pneumoniae in the late-onset Alzheimer's brain | Q33968146 | ||
| A randomized, controlled trial of doxycycline and rifampin for patients with Alzheimer's disease | Q34298526 | ||
| The participation of interleukin-6 in the pathogenesis of alzheimer's disease | Q35155272 | ||
| Infiltration of the brain by pathogens causes Alzheimer's disease | Q35789648 | ||
| Links between the pathology of Alzheimer's disease and vascular dementia | Q35791567 | ||
| Identification of Chlamydia pneumoniae by DNA amplification of the 16S rRNA gene | Q37118408 | ||
| High prevalence of Chlamydia pneumoniae antibodies and increased high-sensitive C-reactive protein in patients with vascular dementia | Q37865107 | ||
| Phagocytes transmit Chlamydia pneumoniae from the lungs to the vasculature. | Q37867354 | ||
| Chlamydia pneumoniae induces Alzheimer-like amyloid plaques in brains of BALB/c mice | Q37867591 | ||
| An MRI study of Chlamydia pneumoniae infection in Italian multiple sclerosis patients. | Q37868355 | ||
| Absence of Chlamydia pneumoniae in brain of vascular dementia patients | Q37868777 | ||
| Chlamydia pneumoniae infection promotes the transmigration of monocytes through human brain endothelial cells | Q37870146 | ||
| Failure to correlate C. pneumoniae with late onset Alzheimer's disease | Q37871632 | ||
| Presence of Chlamydia pneumoniae DNA in the cerebral spinal fluid is a common phenomenon in a variety of neurological diseases and not restricted to multiple sclerosis | Q37874186 | ||
| Chlamydia pneumoniae infection of vascular smooth muscle and endothelial cells activates NF-kappaB and induces tissue factor and PAI-1 expression: a potential link to accelerated arteriosclerosis | Q37877720 | ||
| Endovascular presence of viable Chlamydia pneumoniae is a common phenomenon in coronary artery disease | Q37881317 | ||
| The neuropathology of Alzheimer's disease. | Q40521144 | ||
| Decreased beta-amyloid1-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease | Q40592316 | ||
| Chlamydia pneumoniae: crossing the barriers? | Q43421089 | ||
| Chlamydia pneumoniae-atherosclerosis link: a sound concept in search for clinical relevance | Q43423018 | ||
| Latent herpes simplex virus type 1 in normal and Alzheimer's disease brains | Q44343135 | ||
| High cerebrospinal fluid tau and low amyloid beta42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype. | Q45192211 | ||
| Cytomegalovirus is present in a very high proportion of brains from vascular dementia patients | Q48686786 | ||
| Tau and Abeta42 in cerebrospinal fluid from healthy adults 21-93 years of age: establishment of reference values. | Q48784648 | ||
| Cerebrospinal fluid beta-amyloid(1-42) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease. | Q51983988 | ||
| CSF tau protein and beta-amyloid (1-42) in Alzheimer's disease diagnosis: discrimination from normal ageing and other dementias in the Greek population. | Q53253261 | ||
| Biochemical diagnosis of Alzheimer disease by measuring the cerebrospinal fluid ratio of phosphorylated tau protein to beta-amyloid peptide42. | Q53256600 | ||
| Vascular Dementia Is Underdiagnosed | Q68430771 | ||
| Evaluation of CSF-tau and CSF-Abeta42 as diagnostic markers for Alzheimer disease in clinical practice | Q73632001 | ||
| Association of HSV1 and apolipoprotein E-varepsilon4 in Alzheimer's disease | Q77158998 | ||
| P433 | issue | 2 | |
| P921 | main subject | Alzheimer's disease | Q11081 |
| dementia | Q83030 | ||
| Chlamydia pneumoniae | Q62869737 | ||
| P304 | page(s) | 154-159 | |
| P577 | publication date | 2007-02-21 | |
| P1433 | published in | Journal of Neurology | Q6295649 |
| P1476 | title | Evaluation of CSF-Chlamydia pneumoniae, CSF-tau, and CSF-Abeta42 in Alzheimer's disease and vascular dementia | |
| P478 | volume | 254 |
| Q94397588 | Antibiotics and antivirals for dementia and mild cognitive impairment |
| Q36449877 | Can infections cause Alzheimer's disease? |
| Q40984218 | Cerebrospinal Fluid from Alzheimer's Disease Patients Contains Fungal Proteins and DNA. |
| Q37743247 | Chlamydia pneumoniae infection and Alzheimer's disease: a connection to remember? |
| Q37935917 | Emerging roles of pathogens in Alzheimer disease |
| Q44143219 | Eradication of Helicobacter pylori may be beneficial in the management of Alzheimer's disease |
| Q26781578 | Herpes Simplex Virus Type 1 and Other Pathogens are Key Causative Factors in Sporadic Alzheimer's Disease |
| Q60046815 | Microorganisms' Footprint in Neurodegenerative Diseases |
| Q22305814 | Role of Infection in the Pathogenesis of Alzheimerʼs Disease |
| Q37845820 | Tau and p-tau as CSF biomarkers in dementia: a meta-analysis |
| Q58599989 | The Possibility of an Infectious Etiology of Alzheimer Disease |
Search more.